Please login to the form below
NDA
NDA is Europe’s leading regulatory affairs consultancy, providing clients with a unique insight into EU regulatory thinking and the best possible expert guidance and support to optimise the time to the European market. Year on year, NDA has contributed towards more than 30% of new medicinal products receiving CHMP opinions, through strategic advice and operational support.
This is a FREE listing
Below are full profiles from other companies in this area
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer.
Creative Medical Research
Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making connections with clients and research participants alike. Flexibility, creativity and the desire to do what is right for your business drive what we do.
Syneos Health™
Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.
Company Details
NDA
Telephone:+44 1372 860610
Address:
Prime House
Challenge Court
, Barnett Wood Lane
Leatherhead
Surrey
KT22 7DE
United Kingdom
Latest content from PMHub
- Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
- The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint in this week's instalment of our Pharma and COVID-19 series by Rare Immunology Global Medical Lead Karen Cheng
Frontera Group
- Visual Storytelling in HealthTech
- In the latest episode of Impetus Digital's Fireside Chat, I sit down with Rodney Hu, founder of 209|Digital and a popular podcast host. We explore Rodney’s work within the HealthTech space and what he believes has to happen for the healthcare industry to more readily adopt new digital technologies. We also discuss how Rodney’s experiences with working as an MRI technologist and with being a patient himself have impacted on his work and vision for the future.
Impetus Digital
- Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- In the latest episode of Impetus Digital's Fireside Chat, I talk with Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals. Sandra has extensive experience working in physician, patient, and brand strategy; product marketing; digital; and KOL engagement. We discuss a variety of topics, from the impact of COVID-19 on the way that Pharma teams interact with internal stakeholders and KOLs to the challenges it has brought for healthcare marketing and sales. We also dive into the lessons learned from Sandra’s work on patient education and advocacy, and much more.
Impetus Digital
- Roles of Neuroscience & AI in Solving Complex Healthcare Challenges
- In this episode of Impetus Digital's Fireside Chat, I sit down with Dr. Phillip Alvelda, CEO and Co-Founder of Brainworks and discuss all things artificial intelligence and machine learning. We also explore the concepts of whole-brain AI systems and ambient biometrics, and how AI-enhanced vital sign tracking through a mobile device can be used to monitor for COVID-19 and other conditions.
Impetus Digital
